Browsing by Author Lasarte, J.J. (Juan José)

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 24 to 43 of 118 < previous   next >
Issue DateTitleTypeAuthor(s)
2014Desarrollo de nuevos métodos de vacunación basados en la anafilotoxina C5a y la proteína extra A de la fibronectina y péptidos sintéticos inhibidores de las células T reguladorasTesisRudilla, F. (Francesc)
1999Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxideArticuloLasarte, J.J. (Juan José); Corrales, F.J. (Fernando José); Casares, N. (Noelia); Lopez-Diaz-de-Cerio, A. (Ascensión); Qian, C. (Cheng); Xie, X. (Xiaoming); Borras-Cuesta, F. (Francisco); Prieto, J. (Jesús)
2011Dynamic of nasal colonization by methicillin-resistant Staphylococcus aureus ST398 and ST1 after mupirocin treatment in a family in close contact with pigsArticuloLozano, C. (Carmen); Aspiroz, C. (Carmen); Lasarte, J.J. (Juan José); Gomez-Sanz, E. (Elena); Zarazaga, M. (Myriam); Torres, C. (Carmen)
2022Electroporación irreversible: presente y futuro en el tratamiento del carcinoma hepatocelularArticuloCano, D. (David); Lasarte, J.J. (Juan José); Vivas, I. (Isabel)
2007Engineered promiscuous T helper peptides for the induction of immune responsesArticuloRuiz, M. (Marta); Llopiz, D. (Diana); Zabaleta, A. (Aintzane); Lasarte, J.J. (Juan José); Borras-Cuesta, F. (Francisco); Sarobe, P. (Pablo)
2003Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responsesArticuloLopez-Diaz-de-Cerio, A. (Ascensión); Lasarte, J.J. (Juan José); Casares, N. (Noelia); Sarobe, P. (Pablo); Ruiz, M. (Marta); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco)
2019Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma modelArticuloLlopiz, D. (Diana); Ruiz, M. (Marta); Villanueva, L. (Lorea); Iglesias-Alonso, T. (Tamara); Silva, L. (Leyre); Egea, J. (Josune); Lasarte, J.J. (Juan José); Perrine, P. (Perrine); Trochon-Joseph, V. (Véronique); Vasseur, B. (Bérangère); Dixon, G. (Graham); Sangro, B. (Bruno); Sarobe, P. (Pablo)
2011Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cellsArticuloEcheverria, I. (Itziar); Pereboev, A. (Alexander); Silva, L. (Leyre); Zabaleta, A. (Aintzane); Riezu-Boj, J.I. (José Ignacio); Bes, M. (Marta); Cubero, M. (María); Borras-Cuesta, F. (Francisco); Lasarte, J.J. (Juan José); Esteban, J.I. (Juan Ignacio); Prieto, J. (Jesús); Sarobe, P. (Pablo)
2005Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirusArticuloArribillaga, L. (Laura); Sarobe, P. (Pablo); Arina, A. (Ainhoa); Gorraiz, M. (Marta); Borras-Cuesta, F. (Francisco); Ruiz, J. (Juan); Prieto, J. (Jesús); Chen, L. (Lieping); Melero, I. (Ignacio); Lasarte, J.J. (Juan José)
1993Enhancement of peptide immunogenicity by insertion of a cathepsin B cleavage site between determinants recognized by B and T cellsArticuloSarobe, P. (Pablo); Lasarte, J.J. (Juan José); Larrea, E. (Esther); Golvano, J.J. (José Javier); Prieto, I. (Inés); Gullon, A. (Arturo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco)
2002Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacementsArticuloHuarte, E. (Eduardo); Sarobe, P. (Pablo); Lu, J. (Jun); Casares, N. (Noelia); Lasarte, J.J. (Juan José); Dotor, J. (Javier); Ruiz, M. (Marta); Prieto, J. (Jesús); Celis, E. (Esteban); Borras-Cuesta, F. (Francisco)
2021Epigenetic modifiers: anti-neoplastic drugs with immunomodulating potentialRevisionMaes, K. (Ken); Mondino, A. (Anna); Lasarte, J.J. (Juan José); Aguirre-Ena, X. (Xabier); Vanderkerken, K. (Karin); Prosper-Cardoso, F. (Felipe); Breckpot, K. (Karine)
2021Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variantsArticuloConde-Gallastegi, E. (Enrique); Vercher-Herráez, E. (Enric); Soria-Castellano, M. (Marta); Suarez-Olmos, J. (Jesús); Mancheño, U. (Uxua); Elizalde, E. (Edurne); Rodríguez, M.L. (M. Luis); González-Vaz, J. (Javier); Casares, N. (Noelia); Rodríguez-García, E. (Estefanía); Hommel, M. (Mirja); González-Aseguinolaza, G. (Gloria); Uranga-Murillo, I. (Iratxe); Pardo, J. (Julián); Alkorta-Aranburu, G. (Gorka); Melero, I. (Ignacio); Lasarte, J.J. (Juan José); Hervas-Stubbs, S. (Sandra)
2011Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectinArticuloMansilla, C. (Cristina); Berraondo, P. (Pedro); Durantez, M. (Maika); Martinez, M. (Marta); Casares, N. (Noelia); Arribillaga, L. (Laura); Rudilla, F. (Francesc); Fioravanti, J. (Jessica); Lozano-Moreda, T. (Teresa); Villanueva, L. (Lorea); Sarobe, P. (Pablo); Borras-Cuesta, F. (Francisco); Leclerc, C. (Claude); Prieto, J. (Jesús); Lasarte, J.J. (Juan José)
1996Fine analysis of immunoreactivity of V3 peptides: antibodies specific for V3 domain of laboratory HIV type 1 strains recognize multiple V3 sequences synthesized from field HIV type 1 isolatesArticuloBoudet, F. (Florence); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Borras-Cuesta, F. (Francisco); Theze, J. (Jacques)
1996Further insights on the inhibition of HIV type 1 infection in vitro by CD4-modified synthetic peptides containing phenylalanineArticuloPrieto, I. (Isidro); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Golvano, J.J. (José Javier); Civeira, M.P. (María Pilar); Gullon, A. (Arturo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco)
2015Genetic basis for clinical response to CTLA-4 blockadeArticuloMelero, I. (Ignacio); Lasarte, J.J. (Juan José)
2019Genetic modification of CD8+ T cells to express EGFR: Potential application for adoptive T cell therapiesArticuloLozano-Moreda, T. (Teresa); Chocarro, S. (Silva); Martin, C. (Celia); Lasarte-Cia, A. (Aritz); Valle, C. (Cynthia) del; Gorraiz, M. (Marta); Sarrión, P. (Patricia); Ruiz-de-Galarreta-Martínez, M. (Marina); Lujambio, A. (Amaya); Hervas-Stubbs, S. (Sandra); Sarobe, P. (Pablo); Casares, N. (Noelia); Lasarte, J.J. (Juan José)
2013Helper cell-independent antitumor activity of potent CD8+ T cell epitope peptide vaccines is dependent upon CD40LArticuloLlopiz, D. (Diana); Huarte, E. (Eduardo); Ruiz, M. (Marta); Bezunartea, J. (Jaione); Belsue, V. (Virginia); Zabaleta, A. (Aintzane); Lasarte, J.J. (Juan José); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco); Sarobe, P. (Pablo)
3-Mar-2011Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infectionArticuloRiezu-Boj, J.I. (José Ignacio); Larrea, E. (Esther); Aldabe, R. (Rafael); Guembe, L. (L.); Casares, N. (Noelia); Galeano, E. (E.); Echeverria, I. (Itziar); Sarobe, P. (Pablo); Herrero, J.I. (José Ignacio); Sangro, B. (Bruno); Prieto, J. (Jesús); Lasarte, J.J. (Juan José)